Medical Technology Acquisition Opportunity

ACT Capital Advisors is pleased to offer Medical Technology Assets (including patents and other intellectual property) for acquisition. The physical assets and IP relate to proprietary hemostatic dressings and materials and represent one of the first meaningful solutions for life-threatening hemorrhagic events. 

Technology Overview #210905

Confidentiality Agreement #210905 (Downloadable)

Confidentiality Agreement #210905 (E-Sign with Citrix RightSignature)

If you are interested in pursuing this acquisition further, kindly execute the Confidentiality Agreement linked above and return it to Dan Nicklaus at dnicklaus@actcapitaladvisors.com. If you have questions, you can reach Dan Nicklaus at 206-920-5832.

Leave a Reply

Your email address will not be published. Required fields are marked *